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doi:10.1016/j.ejvs.2010.04.009Abstract Objective: Agenesis of the inferior vena cava (IVC) is a rare vascular malformation.
Deep vein thrombosis (DVT) and bilateral pelvic thrombosis develop quite frequently, making
surgical therapy necessary.
Patients and methods: Between 1982 and 2006, 15 patients (nine male, six female, mean age
28 standard deviance 9 years) with agenesis of the IVC (IVCA) were treated surgically because
of acute or subacute DVT. These patients underwent bilateral transfemoral ante- and retro-
grade thrombectomy of the iliofemoral and sometimes popliteal veins and replacement of
the IVC with an external ring supported PTFE-graft. Bi- or unilateral arteriovenous fistulae
were created in the femoral region. The fistulae were closed, on average, 8 months after
trans-arterial venography was performed. These patients were examined clinically and by
duplex ultrasound imaging during follow-up to assess graft patency and to allow CEAP classifi-
cation. Patients were assessed for the development of post-thrombotic syndrome (PTS).
Results: No patient died during any part of their treatment or within 60 days. Primary patency
of the venous reconstruction was 53%, secondary and long time follow-up patency was 83%.
The mean duration of follow-up was 41 SD 12 months. Minor complications were observed in
five cases (33%). PTS showed no progression during a follow-up of 41 SD 12 months in all
patients. There was no change in the CEAP clinical stage during follow-up nor did any leg ulcer
develop.
Conclusion: A surgical approach to restore venous patency is effective and appears to prevent
the deterioration of CVI over time.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.1 8117090; fax: þ49 211 8116603.
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242 T.A. Sagban et al.The venous drainage from the lower limbs, pelvic organs,
retroperitoneal space, the liver, abdominal wall and the
distal part of the spine relies on patency of the inferior
vena cava (IVC). Congenital malformations of the IVC are
rare anomalies which are usually detected incidentally
during surgery, angiography, computed tomography (CT)
scans or autopsy.1 The IVC in humans develops between the
third and eighth week of embryonic life. The incidence of
IVC anomalies is reported to be between 0.3% and 10%.2
The diagnosis may be established incidentally or after an
episode of deep venous thrombosis (DVT) or when DVT or
severe venous insufficiency develops at a young age. The
most common anomaly of the IVC is aplasia and hypoplasia,
where the venous blood from the lower part of the body is
drained through the azygous system into the superior vena
cava.3 The azygous veins dilate together with lumbar veins
and compensate the venous capacity of the lower extrem-
ities. Complete aplasia of the IVC is often combined with
congenital heart failure and has an incidence of 0.6e2%.3
Lin and colleagues describe anomalies of the inferior and
superior vena cava linked with Goldenhar syndrome and
a lefteright asymmetry with heart failure.4
IVC anomalies remain asymptomatic as long as venous
flow from the lower part of the body is compensated by
collateral flow, which is the case in 25% of the patients.5
When thrombogenic risk factors accompany the IVC
anomaly, DVT often affects the iliofemoral veins on both
sides. Renal vein thrombosis, chronic venous insufficiency
with severe skin ulceration and gastrointestinal bleeding
caused by ruptured duodenal varicosis can be caused also
when the azygous vein is ligated incidentally in thoracic
surgical procedures. Reduced venous drainage causes
chronic venous obstruction with varicosities, oedema or
trophic skin changes of venous disease. Systemic symp-
toms (such as cyanosis, dyspnoea, myocardial insufficiency
or dilatation and growth retardation in children) may
occur.
This malformation may be treated in one of the two
ways when DVT occurs e by conservative therapy with anti-
coagulation and compression stockings, and treatment of
any further complication which may arise e or by prosthetic
surgical replacement of the IVC in combination with deep
venous thrombectomy and temporary arteriovenous fistula.
Surgery is indicated not only because of significantly
elevated venous pressure but also to avoid the develop-
ment of a severe post-phlebitic syndrome (PTS), the
severity of which is related to the extent of the DVT.6Figure 1 Example of a biiliacal-right-atrial bypass.Patients and Methods
A retrospective analysis of a consecutive series of 820
patients, who presented for urgent or emergency surgical
treatment for DVT between January 1982 and June 2006 at
our institution, was conducted. Analysis of data was
approved by the local ethics committee, and informed
consent was obtained from each patient. Recorded patient
details included demographic characteristics, pre-existing
co-morbidities, cardiovascular risk factors as well as
a history of previous surgery, clinical presentation, imaging
studies, diagnosis and intra-operative details, and early
(30- and 60-day or in-hospital) morbidity and mortality.Between January 1982 and June 2006 187 patients
underwent venous thrombectomy of the IVC. In 15 patients,
the IVC was not detectable by pre-operative imaging and
agenesis of the IVC was found (IVCA) at surgery. The clas-
sification described by Bass for vena cava agenesis7 was
used to classify patients. We used the clinical part of the
revised CEAP classification6 to record the pre-operative
state of the limb. Blood was taken for thrombophilia
screening which included factor V Leiden, prothrombin
gene mutation (G20210A), methyltetrahydrofolate reduc-
tase gene mutation (MTHFR), Gp807 and GAI1. After surgery
all patients were anti-coagulated with coumadin and wore
class 2 medical compression stockings.
Patients were reviewed in the clinic following
surgery
Follow-up examinations included clinical and ultrasound
evaluation every 3 months in the first year. We used clinical
examination with a focus on leg swelling and collaterals in
the pelvis and abdomen. Duplex ultrasonography was per-
formed of the abdomen, pelvis and legs, plethysmography
and light reflection rheography. A CT/magnetic resonance
imaging (MRI) scan was obtained 6 months post-operatively.
In cases of doubtful patency of the reconstruction, a CT
scan was performed earlier (Fig. 1). After the first year of
Table 1 Surgical procedure and region of anastomosis.
Procedure % n
Primary replacement without thrombectomy
of IVC
20 3
Primary replacement with thrombectomy
of IVC
67 10
Thrombectomy with secondary replacement
of IVC
13 2
Anastomosis
Right iliac vein e left persistent IVC 7 1
Both iliac veins e IVC infrarenal 7 1
Both iliac veins e IVC intrarenal 7 1
Left iliac vein e right atrium 7 1
Right iliac vein e right atrium 7 1
Both iliac veins e right atrium 13 2
IVC-above confluence e IVC- at the level of
the Renal veins
7 1
IVC e rı´ght atrium 40 6
IVC-suprarenal e V. lienalis 7 1
Total 15
Surgical Treatment for Agenesis of the Vena Cava 243surgery, we examined our patients once a year. A CT or MRI
scan was an essential part of this assessment, which also
included clinical examination and duplex ultrasonography
as described earlier. To complete re-coding of venous
status during follow-up, the degree of PTS according to the
revised clinical part of CEAP6 was assessed.
Statistical Methods
Continuous variables are summarised as mean and standard
deviation when normally distributed, and as median and
interquartile range when non-normally distributed. Cate-
gorical variables are presented as numbers and percent-
ages. Data were analysed using SPSS for Windows, version
15.0 (SPSS, Inc, Chicago, IL, USA).
Results
Symptoms and risk factors
Fifteen patients with a mean age of 28 years (range 17e48
years, nine male, six female) were found with IVCA. They
underwent surgery for complications of IVCA. In 12 cases
(80%), acute or subacute thrombosis was clinically evident
and in one case, pulmonary embolism was found. In one
case, surgery was performed because of a ruptured aneu-
rysm of an ovarian vein8 and one patient was treated
surgically because of an aneurysm of the iliac vein and the
femoro-popliteal vein.
Eight (53%) of the patients could not be classified using
the Bass system,7 40% (n Z 6) were grouped in Bass 9 and
one patient was grouped in Bass 3 and another one in Bass 5.
In four cases, the patients were active smokers and oral
contraceptives were being taken in three cases (50% of
women). Cardiorespiratory disease was found in only one
case and one patient suffered from a salmonella enteritis
infection. Family history of venous thrombo-embolism was
negative in all cases of IVCA. One patient had already
developed leg ulcers (he was the oldest one in this group,
aged 48 years, and already had a history of multiple
thrombosis with PTS). Fourteen of 15 cases showed
thrombophilia according to our laboratory findings (93%). In
six patients, heterozygous factor V Leiden gene mutation
was identified as a risk factor for development of DVT
(40%), in one case prothrombin gene mutation was present.
Eight patients (53%) had MTHFR gene mutation, in six this
was heterozygous and was homozygous in the remaining
two. A number of patients had multiple genetic risk factors
(two genetic combinations, n Z 4; three genetic combi-
nations, n Z 4). In three cases, the patients suffered from
heparin-induced thrombocytopaenia (HIT II, 20%) pre-
operatively, two patients had lysis with urokinase and in
three cases venous thrombectomy had already been
carried out elsewhere before patients presented at our
clinic.
Surgery
The indications for surgery were acute thrombosis in nine
cases (60%), post-thrombotic syndrome (CEAP > 3) in five
cases (33%) and bleeding from a venous aneurysm in one.8The surgical approach was performed in nine cases
through a thoraco-abdomino-inguinal incision, abdomino-
inguinal in four cases, thoraco-abdominal in one case and
abdominal incision in one. In order to prevent re-throm-
bosis in all cases, an arteriovenous fistula was constructed
in the groin in all cases, bilateral in eight and unilateral in
seven cases. The extent of thrombectomy and/or replace-
ment of the IVC is presented in Table 1 with distal and
proximal anastomotic region. In eleven cases an external
ring-reinforced ePTFE tube was used for IVC replacement;
a bifurcated prosthesis was used in four cases. Main body
diameter varied from 13 to 20 mm. The arteriovenous
fistulae were closed on average at 8.2 months (minimum
two months, maximum 18 months). The patency of the
bypass graft was confirmed by trans-arterial venography
before the fistula was closed. Trans-arterial venography is
performed identically to arteriography/angiography but
displays the reconstructed venous segments via the arte-
riovenous fistula. The arteriovenous fistula was surgically
transected after three months if the arteriogram (Ztrans-
arterial venography) showed a patent reconstruction. If
arteriovenous fistulae were present in both groins, the
second one was surgically closed after a further 6 weeks
following closure of the first one.
Mortality and morbidity
None of the patients died during or after surgery and the
30- and 60-day in-hospital mortality was zero. In all
patients, successful revascularisation of the venous system
was achieved by the time treatment was concluded. During
the first 9 post-operative days early occlusion and re-
thrombosis occurred in seven cases which required addi-
tional treatment to achieve patency. Occluded grafts were
treated by surgical thrombectomy using a Fogarty embo-
lectomy catheter with gate valve (Edwards Lifesciences,
Unterschleissheim, Germany). Deep femoral vein in the
Table 2 Minor postoperative complications.
% n Z 15
Inguinal lymph fistula 13 2
Wound infection inguinal 7 1
Psoas haematoma 7 1
Pneumonia 7 1
None 67 10
244 T.A. Sagban et al.groin was used as access site always. A small number of
minor complications including haematoma and lymph
fistula were encountered during treatment (see Table 2).
Follow-up
The late outcome of treatment was established in 12 of 15
remaining patients. Three patients declined to return for
follow-up. The mean duration of follow-up was 41 SD 12
months. In 10 of the 12 cases reviewed, the IVC replace-
ment graft was patent and venous flow had been re-
established along the normal anatomical path. In two
cases, the reconstruction had become occluded and venous
flow took place via collateral vessels. The CEAP clinical
stages of patients before treatment and after a mean of 41
months of follow-up are shown in Table 3. In general, there
was no clinical deterioration during follow-up and no case
of leg ulceration developed.
Discussion
The frequency of DVT in Western populations is estimated
to be one in 1000 individuals per annum.9,10 This varies with
age and in adults aged between 20 and 40 years, the inci-
dence is 10 times lower.11 DVT has a multifactorialTable 3 CEAP clinical stage; pre- and postoperative
comparison of post-thrombotic changes for all patients
after follow up (n Z 12; 41 SD 12 months).
1
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3
0
pre post
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n=6 CEAP 0
n.s.aetiology involving both acquired and genetic factors.
Factors that predispose to DVT cause a state of hyperco-
agulability or venous flow alteration with stasis. While
hypercoagulability may result from both congenital and
acquired risk factors, most situations in which stasis
contributes to DVT risk result from bed rest and immobili-
sation due to trauma, surgery and congenital anomalies of
the inferior vena cava such as atresia or aplasia. This may
be present in childhood if the defect is combined with
congenital anomalies of the heart, polysplenia and/or
bowel inversion. Patients without associated conditions are
typically asymptomatic and the defect is only encountered
incidentally during abdominal surgery or radiological
procedures. The azygous and portal venous systems provide
sufficient collateral venous return. However, the absence
of IVC may favour venous stasis and therefore represents
a risk factor for DVT.
Total and partial agenesis of the IVC seem to be asso-
ciated with a high rate of DVT. For a thrombotic event
usually a further risk factor (venous stasis, immobilisation,
etc.) or disposition (thrombophilia) is needed.6 In our
series, 14 of 15 patients had inherited thrombophilias
including several patients with multiple thrombophilias. It
is well known that DVT has a multifactorial aetiology
involving both genetic and acquired factors.12 The preva-
lence of IVC atresia in referral population for the study
centre and the prevalence of coagulation abnormalities in
the asymptomatic patients with IVCA are unknown.
Compared with our other DVT patients in the registry
without IVCA this difference is significant. The frequency of
factor V Leiden gene mutation in a normal population is
about 5%, but in our series DVT in combination with IVCA
the incidence was 40%. Probably this is the result of
selection because we only see IVCA in combination with
a DVT in our hospital.
Our follow-up data show stabilisation of the clinical
stage of venous disease after treatment. In one patient who
had suffered ulceration of both legs for 30 years; IVS
replacement resulted in long-term ulcer healing. No patient
showed deterioration of their CVI post-operatively. Surgery
is indicated in patients who show deterioration of the
clinical stage of CVI or for acute thrombosis of the iliofe-
moral veins which causes complete collapse of the collat-
eral system. DVT may arise in patients with IVCA as they
age due to the increased risk of DVT with advancing
age.12,13 The value of undertaking reconstructive surgery of
the IVC before the onset of DVT cannot be readily estab-
lished since there is no simple screening test for IVCA which
could be employed to identify such patients. Abnormality
of IVC cannot be detected by ultrasonography.13,14 The
primary diagnosis of a venous thrombosis should rely on
duplex ultrasound imaging and further diagnostic tests
should be used when bilateral symptoms are present and
extension of the thrombosis into the proximal iliac veins
and IVC is suspected. In those patients, duplex examination
should be followed by CT scanning or where this is contra-
indicated, by MRI angiography.15,16
The aim of a successful surgery is to prevent steady
deterioration of CVI with the passage of time which might
otherwise culminate in debilitating leg ulceration in many
cases. We consider that construction of a temporary arte-
riovenous fistula in the groin to accelerate blood flow
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venous patency. After 3 months the arteriovenous fistula
may be closed. It is our standard practice to perform trans-
arterial venography before closing fistulae to detect any
deterioration in the replaced venous segment.
Heparinisation followed by long-term anti-coagulation
with coumadin maintains patency of the venous system and
medical compression stockings help to protect the legs
from skin changes. Lifelong anti-coagulation with coumadin
should be considered in all cases when thrombophilia is
present.
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